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Abstract
Background: Streptococcus pneumoniae, particularly penicillin-resistant strains (PRSP), constitute
one of the most important causes of serious infections worldwide. It is a fastidious microorganism
with exquisite nutritional and environmental requirements to grow, a characteristic that prevents
the development of useful animal models to study the biology of the microorganism. This study was
designed to determine optimal conditions for culture and growth of PRSP.
Results: We developed a simple and reproducible method for culture of diverse strains of PRSP
representing several invasive serotypes of clinical and epidemiological importance in Colombia.
Application of this 3-step culture protocol consistently produced more than 9 log10 CFU/ml of
viable cells in the middle part of the logarithmic phase of their growth curve.
Conclusion: A controlled inoculum size grown in 3 successive steps in supplemented agar and
broth under 5% CO2 atmosphere, with pH adjustment and specific incubation times, allowed
production of great numbers of PRSP without untimely activation of autolysis mechanisms.
Background
Streptococcus pneumoniae, one of the most important
human pathogens of all times, is today an even more seri-
ous menace because of its increasing resistance to penicil-
lin, the first-choice antibiotic [1]. It is a fastidious
organism to grow both in vitro and in animal infection
models. Probably because of the wide genetic diversity of
this organism and its exclusive nature as human patho-
gen, it is difficult to obtain comparable cell production
when culturing different strains even within the same
serotype [2].
In the field of experimental animal models there is also
wide variation in the susceptibility of mice strains and
specific organs to infection with S. pneumoniae [3,4].
While new drugs with activity against penicillin-resistant
S. pneumoniae (PRSP) are being discovered, only penicil-
lin-susceptible strains grow in the lungs of experimental
animals with some consistency [5]. Although other organs
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such as the thighs of neutropenic mice are susceptible to
progressive infection with PRSP, a reproducible pneumo-
nia model remains elusive for most strains of PRSP.
Little attention has been given to the culture conditions of
S. pneumoniae, critical to obtain the appropriate amount
of viable log-phased cells to inoculate the animals. S.
pneumoniae was reclassified within the group of anaerobic
bacteria because its relatively small genome simply lacks
many genes required for aerobic growth [6]. As a Gram-
positive catalase-negative coccus that generates H2O2 via a
flavoenzime system, it grows better in presence of a source
of catalase such as red blood cells [7,8]. In contrast to
most bacteria, S. pneumoniae also requires choline for
growth in defined media, and reducing agents are almost
essential. Growth of most strains requires vitamin B com-
plex (biotin, nicotinamide, pantothenate, pyridoxal, ribo-
flavin and thiamine), adenine, guanine, uracil, and 7–10
amino acids. Its energy metabolism is fermentative, yield-
ing primarily low levels of lactic acid, but optimum pH for
growth is 7.8 with a range of 6.5–8.3 [9]. Besides these
limitations, S. pneumoniae displays a particularly effective
quorum sensing system that activates several potent
autolysins once certain conditions are met within the
growing population, and this is perhaps the most impor-
tant hurdle to overcome when trying to obtain viable log-
phased cells [10]. Among several factors not well under-
stood, culture acidification is one of the conditions met by
the growing population that clearly contributes to start
the autolysis process [11].
We hypothesized that optimization of culture conditions
tending to prevent environmental acidification and its
consequent activation of autolysis mechanisms could lead
to better production of PRSP in vitro, and aimed to deter-
mine and provide such ideal conditions for the growth of
this microorganism, so they could be applied to diverse
strains of clinical importance to develop a reproducible
animal model of pneumonia.
Results
Susceptibility testing
Minimal inhibitory (MIC) and bactericidal (MBC) con-
centrations of six antimicrobial agents for these strains are
shown in Table 1. Reduced susceptibility to penicillin was
demonstrated for 6 strains, the other 2 were susceptible.
Among those non-susceptible, 4 strains displayed inter-
mediate (MIC 0.12–1 µg/mL) and 2 full resistance to pen-
icillin (MIC > 1 µg/mL). Only one strain (INS-E685) was
susceptible to all six antibiotics tested, but all of them
were susceptible to erythromycin and vancomycin. MIC
of ceftriaxone against PRSP INS-E611, E674 and E676 was
1 µg/mL, a value conferring intermediate resistance for
CSF isolates, as was the case for strain INS-E676 (Table 1).
Evaluation of baseline culture variables
The results are summarized in Table 2. For cryoprotection,
skim milk invariably allowed recuperation of frozen
organisms, while 17% glycerol failed once (no viable bac-
teria after thawing). During Phase 0, we found that two
successive passes on solid media were necessary for com-
plete recuperation after thawing, and that their optimal
incubation time was 15 hours. After 15 hours colony
umbilication became deeper, suggesting progression of
the autolysis process [9]. The number of colonies from
Table 1: Serotypes and minimal inhibitory and bactericidal concentrations (MIC / MBC) of six antimicrobial agents against nine strains 
of Streptococcus pneumoniae
Strains Serotype MIC / MBC [µg/mL] MIC* [µg/mL]
PEN CRO VAN ERY CHL SXT
INS-E611 6B 2.00 / 2.00 1.00 / 1.41 0.35 / 0.35 0.03 32.00 4.00
INS-E674 14 2.00 / 2.00 1.00 / 1.00 0.25 / 0.25 0.06 4.00 8.00
INS-E676 14 1.00 / 1.41 1.00 / 1.41 0.35 / 0.70 0.06 4.00 8.00
INS-E678 14 0.12 / 0.12 0.03 / 0.03 0.25 / 0.25 0.06 4.00 16.00
INS-E682† 6B 0.01 / 0.01 0.01 / 0.01 0.25 / 0.25 0.06 32.00 0.50
INS-E683 9V 1.00 / 1.00 0.35 / 0.35 0.35 / 0.35 0.06 4.00 32.00
INS-E684 14 1.00 / 1.00 0.50 / 0.50 0.25 / 0.25 0.13 4.00 1.00
INS-E685† 1 0.01 / 0.01 0.01 / 0.01 0.25 / 0.25 0.06 2.00 0.50
ATCC 49619 19F 0.46 / 0.46 0.06 / 0.12 0.33 / 0.44 0.06 4.00 0.25
PEN = penicillin; CRO = ceftriaxone; VAN = vancomycin; CHL = chloramphenicol; ERY = erythromycin; SXT = trimethoprim-sulfamethoxazole 
(only first component values shown)
* MIC determined by Instituto Nacional de Salud (INS), Bogotá, Colombia.
† Breakpoint for penicillin-susceptible strains: MIC ≤  0.06 µg/mL.BMC Microbiology 2005, 5:34 http://www.biomedcentral.com/1471-2180/5/34
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Phase 0 employed to inoculate Tube 1 in Phase 1 was crit-
ical to maximize the number of viable log-phased cells: 10
colonies into 10 ml of culture broth gave the best results.
Since broth acidification is known to start autolysis, a low
pH after 12 hours of incubation during Phase 1 was used
as an indicator of poor viability. Compared with 10
colonies, 5 or less produced lower cell numbers with sim-
ilar decrease in pH, and 15 or more colonies gave greater
cell numbers but with a profound decrease in pH (Table
3). Besides 5% sheep blood, additional supplementation
of trypticase soy agar (TSA) with 0.5% yeast extract
(instead of 0%) during Phase 0 increased the number of
viable cells produced by broth culture in Phase 1 from
6.60–7.60 to 8.32–8.63 CFU/ml.
The type of liquid media was tested before (standard
broth) and after diverse adjustments (supplemented
broth). Standard Todd Hewitt Broth (THB) was more reli-
able than Brain Heart Infusion (BHI) made by Oxoid and
BBL, because it consistently produced 1.63–2.64 log10
CFU/ml per hour with all strains and lots tested. BBL-BHI
production was low (1.34–1.63 log10 CFU/ml per hour)
from the beginning and not used further. BHI Oxoid was
similar to THB in cell production, but not reproducible
with the different lots tested to grow strain INS-E611 (Fig-
ure 1). Analysis of these four media by repeated measures
ANOVA demonstrated a non-significant difference (P =
0.7976), as expected from the similarity in production
during the first few hours of cultivation. However, as illus-
trated by Figure 2, productivity at the end of each culture
(5 hours) was significantly better with supplemented THB
compared with standard THB and BHI (P = 0.0022, one
way ANOVA). While stationary and death phase with ≤
8.0 log10 CFU/ml was reached before 3 hours with stand-
ard broths, supplementation of THB consistently pro-
duced  ≥  9.0 log10 CFU/ml and prolonged logarithmic
growth during Phase 2 up to 4 hours in Tube 6, 5 hours in
Tube 7, and 7 hours in Tube 8 (Figure 3). Incubation time
during Phase 1 was best at 12 hours, with longer periods
resulting in poor growth during Phase 2, mainly deter-
mined by media acidification. Adjustment of pH was fun-
damental during both Phase 1 and Phase 2. For practical
reasons, Phase 1 broth was adjusted at the beginning of
the 12-hour culture, but Phase 2 broth was adjusted every
hour. In Figures 1, 2, 3, the term "supplemented" also
implies this protocol for pH adjustment.
Supplementation and optimization of culture conditions 
for PRSP
Optimized culture conditions produced ≥  9 log10 CFU/ml
of log-phased cells in Phase 2. These results were repro-
ducible with all PRSP strains tested (Figure 4) under the
following protocol:
Table 2: Comparison of diverse culture variables for productivity of PRSP cells
Variable Phase 0 Phase 1 Phase 2
Cryoprotection Media SM > 17%G:TSB NA NA
Inoculum (colonies) NA 10 > 5 or 15 or loopful NA
Culture Broth NA THB > BHI THB > BHI
Yeast Extract (% YE) 0.5 > 0 2.0 > 0 2.0 > 0
Horse Blood (% HB) NA 2.5 > 0 2.5 > 0
pH adjustment to 7.8 NA Initially > NoAdj q1h > NoAdj
Incubation time (h) 15 > 18 > 24 12 > 15, 18, 24 3*, 5†, 6‡
Ideal dilution (Tube #) NA 5 > 4 > 1–3 6 = 7 = 8
SM = Skim Milk; > implies "superior to"; NA = non applicable to that Phase; 17%G:TSB = 17% glycerol in trypticase soy broth; THB = Todd Hewitt 
Broth; BHI = Brain Heart Infusion; NoAdj= no adjustment; *Tube 6; †Tube 7; ‡Tube 8.
Table 3: Influence of inoculum size in cell production of Streptococcus pneumoniae INS-E611 after 12 hours of Phase 1 culture in 
supplemented THB
Number of CFU (Phase 0) OD600 nm (Phase 1) Broth pH (Phase 1) Phase 1 Production [log10 CFU/mL]
1 0.381 7.90 7.278
5 1.878 7.00 8.662
10 0.914 – 1.884 7.08 – 7.32 8.884 ± 0.047
15 1.766 6.28 9.067
Loopful 1.778 6.17 8.851BMC Microbiology 2005, 5:34 http://www.biomedcentral.com/1471-2180/5/34
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Phase 0: from frozen stock (skim milk), cells are resusci-
tated by two consecutive passes on 5% sheep blood TSA
supplemented with 0.5% yeast extract and incubated for
15 hours under 5% CO2 atmosphere.
Phase 1: 10 colonies from the second plate are inoculated
into 10 ml of supplemented THB (Tube 1), followed by 4
successive 1:10 dilutions into identical liquid media
(Tubes 2–5). Supplementation implies pH adjustment to
7.8 with 1N NaOH after addition of 2% yeast extract and
2.5% horse blood. All 5 tubes are incubated for 12 hours
under 5% CO2  atmosphere, without additional pH
adjustment.
Phase 2: 1 ml of bacterial suspension taken from the most
diluted tube with visible growth from Phase 1 is inocu-
lated into 9 ml of supplemented THB (Tube 6) in Phase 2.
With most strains and under conditions just described for
Phases 0 and 1, Tube 5 or 4 should have visible growth by
the end of Phase 1. Tubes 3, 2, and 1 should not be used,
because their pH is invariably acidic by the end of Phase
1, usually giving very low cell counts during Phase 2. After
inoculation of Tube 6, two successive 1:10 dilutions are
made into identical media (Tubes 7 and 8). Each one of
these 3 tubes is incubated under 5% CO2 atmosphere, and
their pH is adjusted every hour to 7.8 with 1N NaOH. We
found that optimal incubation periods were 4, 5 and 7
hours for Tubes 6, 7, and 8, respectively.
Discussion
Our results demonstrate that optimization of culture con-
ditions is an easy, non-expensive and reproducible way to
attain penicillin-resistant S. pneumoniae growth over 9.5
log10 CFU/ml without the need of more complex methods
(e.g. chemostat).
The S. pneumoniae serotypes used in this study are repre-
sentative of the most frequent invasive isolates from
blood and CSF in Colombia [20,21].
The three standard media used initially (BHI-Ox, BBL-BHI
and THB) are recommended by American Society for
Microbiology and Clinical Laboratory Standards Institute
(CLSI, formerly NCCLS) for S. pneumoniae growth, but
their productivity was quite different. In contrast with
BHI, THB has soy bean peptone and higher pH (7.4 vs 7.8,
respectively). Conversely, BBL-BHI has the highest dex-
trose concentration (3 g/L), which results in marked acid-
ification of the media as anaerobic growth progresses [2].
In this aspect, we confirmed previous findings of acidic
pH (under 6.5) inhibiting growth of penicillin resistant
and susceptible S. pneumoniae strains [12]. To avoid media
acidification, we limited the number of colonies produced
during Phase 0 to inoculate supplemented THB in Tube 1
(Phase 1) and adjusted pH to 7.8 at the beginning of
Phase 1 and every hour during Phase 2. Since pH control
is not enough to attain growth over 8.7 log10 CFU/ml [12],
we addressed two additional characteristics that influence
S. pneumoniae growth: autolysis and competence. The
process of autolysis takes place around the upper part of
the logarithmic phase of growth, is started by pheromones
liberated by a complex quorum sensor system, and is
characterized by extensive cellular death [10,11]. Compe-
tence, or the capacity for genetic transformation, is well
developed in S. pneumoniae, and particularly well in PRSP,
but it does not happen without repercussion in bacterial
growth, both in vitro and in vivo [3,5,13]. Although the
relationship between autolysis and competence not
always goes in the same direction, choline mutants (the
target of most autolysins) have shown important changes
respect to wild type pneumococci, including abnormal
growth in long chains instead of diplococci, loss of com-
petence for transformation, resistance to autolysis, and
resistance to cell-wall active antibiotics [14]. Based on
these facts, we hypothesized that prevention of autolysis
could improve production of viable cells even in the log-
arithmic phase of bacterial growth. Besides offering a suit-
able culture media, shorter incubation times and separate
Comparison of three standard liquid media with a supple- mented medium for culture of S. pneumoniae INS-E611 Figure 1
Comparison of three standard liquid media with a 
supplemented medium for culture of S. pneumoniae 
INS-E611. Five-hour growth curves for a PRSP strain in four 
different culture media: standard BHI (two brands), standard 
THB, and supplemented THB. All curves were obtained from 
Tube 7 (Phase 2). Bacterial growth was poor in standard 
BBL-BHI, and was not used for further experiments. As 
expected, there was no difference among these media when 
every data point along time was compared by repeated meas-
ures ANOVA (P = 0.7976). However, there was a significant 
difference in maximal growth between supplemented THB 
and standard media, as illustrated by Figure 2.BMC Microbiology 2005, 5:34 http://www.biomedcentral.com/1471-2180/5/34
Page 5 of 8
(page number not for citation purposes)
culture process in three phases allowed generous bacterial
growth before triggering autolysis mechanisms. Given
that concentrations of 8 log10 CFU/ml were obtained 1–2
hours before reaching the maximum incubation periods
shown in Figure 3, inoculation of healthy cells in large
numbers is possible before triggering autolysis and,
probably, while pneumococci are still virulent enough to
induce acute pneumonia in animal models.
Goncalves et al specifically addressing the optimal grow-
ing conditions for S. pneumoniae, described a batch culti-
vation procedure for serotype 23F, suitable for large scale
polysaccharide production to manufacture vaccines [2].
They used Hoeprich's medium with different glucose con-
centrations and supplemented with various amino acids
and a vitamin solution, and provided an anaerobic
environment with N2 or CO2. Their results, expressed in
terms of biomass and polysaccharide production, are dif-
ficult to compare with ours. Moreover, they used autolysis
as a way of releasing polysaccharide, whereas we tried to
avoid this process to obtain viable bacteria.
This is the first report on culture optimization for maxi-
mum growth of PRSP with simple methods, and is
directed to facilitate the use of these strains in experimen-
tal procedures such as the development of animal models
Maximal growth of S. pneumoniae INS-E611 cultured in three liquid media Figure 2
Maximal growth of S. pneumoniae INS-E611 cultured in three liquid media. The graph illustrates cell production of 
each medium after 5 hours of incubation; all cultures were obtained from Tube 7 (Phase 2). Supplemented THB was clearly 
superior to standard THB and BHI.BMC Microbiology 2005, 5:34 http://www.biomedcentral.com/1471-2180/5/34
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of pneumonia. The cultivation conditions described here
generate high concentrations of log-phased bacteria with-
out early and inconvenient induction of autolysis.
Conclusion
In this study we demonstrate that a standardized inocu-
lum grown in supplemented solid and liquid media with
pH adjustment and control of incubation times in three
phases produces viable PRSP far beyond the limiting 8
log10 CFU/mL. This method should allow improvement
in experimental approaches to solve important questions
regarding the biology, pathology, and therapeutics of
PRSP.
Methods
Bacterial strains
Eight clinical strains of Streptococcus pneumoniae, obtained
from very sick patients nationwide, were supplied by the
Colombian Instituto Nacional de Salud (INS). These
included six strains non susceptible to penicillin (called
further penicillin-resistant): INS-E611, E674 (blood iso-
lates), E676, E678, E683, E684 (cerebrospinal fluid iso-
lates); and two penicillin-susceptible strains: INS-E682
(blood isolate) and E685 (cerebrospinal fluid isolate). A
standard strain of PRSP (S. pneumoniae ATCC 49619) was
used as a control for all experiments (Table 1).
Susceptibility testing
MIC and MBC to penicillin, ceftriaxone and vancomycin
were determined by broth microdilution following CLSI
procedures [15]. MIC to the same antibiotics and to chlo-
ramphenicol, trimethoprim-sulfamethoxazole and eryth-
romycin had been determined at the Colombian INS
using identical methodology.
Evaluation of baseline culture variables
Strain INS-E611, a penicillin-resistant strain (MIC = 2.0
µg/mL), was selected to test a wide group of variables
involved in bacterial growth that could have importance
for S. pneumoniae. Once the growth dynamics under each
variable were determined for this strain, the most produc-
tive conditions were standardized and applied to the
remaining strains. Bacterial stocks were stored at -70°C in
two sets of 100 aliquots per strain. Cryoprotection media
included 17% glycerol in trypticase soy broth for one set
Growth of S. pneumoniae INS-E611 during Phase 2 in supple- mented THB Figure 3
Growth of S. pneumoniae INS-E611 during Phase 2 in 
supplemented THB. One-mL bacterial suspension pro-
duced by Tube 5 (Phase 1) after 12 h of incubation was inoc-
ulated into 9-mL fresh broth (Tube 6, 1:10 dilution) and 
diluted further into Tube 7 (1:100) and Tube 8 (1:1000). 
Incubation under 5% CO2 atmosphere and pH adjustment 
every hour followed for 5–6 hours, with simultaneous plating 
for CFU counting. The graph illustrates the time to reach 
maximum growth for each inoculum size before triggering 
autolysis: 4, 5 and 7 hours for Tubes 6, 7 and 8, respectively. 
With this method, very similar maximum growths were 
attained under different inoculum sizes. Experiments with 
each tube were done 1–3 times.
Growth curves of six strains of PRSP under optimized cul- ture conditions Figure 4
Growth curves of six strains of PRSP under opti-
mized culture conditions. The high productivity of viable 
log-phased bacteria demonstrated for S. pneumoniae INS-
E611 was reproduced with other 5 strains of PRSP, including 
diverse serotypes (Table 1). More than 9.0 log10 CFU/mL 
were obtained in a consistent manner with all strains (curves 
shown correspond to Tube 7, Phase 2). The variability 
between strains, evidenced by the time to reach maximal 
growth, is characteristic of S. pneumoniae.BMC Microbiology 2005, 5:34 http://www.biomedcentral.com/1471-2180/5/34
Page 7 of 8
(page number not for citation purposes)
and skim milk for the other. The process from thawing to
the end of variable evaluation was separated in three suc-
cessive steps that we called phases: Phase 0 for resuscitat-
ing the frozen organism on to solid medium (two
successive agar plates), Phase 1 for passing it to 10 ml liq-
uid medium a first time (five 16 × 125 glass tubes labeled
1 to 5 with successive 1:10 dilutions), and Phase 2 for a
second transfer of log-phased cells into 10 ml fresh liquid
medium (three 16 × 125 glass tubes labeled 6 to 8 with
successive 1:10 dilutions). The results were determined
for all culture variables intervening at each phase and for
the whole process by OD580 nm (standard broths) and
OD600 nm (horse-blood supplemented broths) at 20–60
minutes intervals (SPECTRO 22, Labomed, Culver City,
CA, USA); quantification of viable CFU per mL was made
by dilution plating at least every hour during Phase 2.
These variables were tested by separate and combined at
each step: cryoprotection media, addition of 0.5% yeast
extract, and incubation time during Phase 0; inoculum
size (number of CFU per tube), type of standard culture
media, addition of 2% yeast extract and 2.5% horse
blood, initial pH adjustment to 7.8 (744 pH Meter,
Metrohm Ltd., Switzerland) with 1N NaOH (EK CHEM,
Germany), incubation time, and number of the most
diluted tube with visible turbidity (used to inoculate Tube
6) during Phase 1; and type of standard culture media,
addition of 2% yeast extract and 2.5% horse blood, pH
adjustment to 7.8 every hour, incubation time, and bacte-
rial growth rate from Tubes 6, 7 and 8 during Phase 2. All
three phases included incubation under 5% CO2 atmos-
phere. Three types of standard culture media were evalu-
ated in Phases 1 and 2: Brain Heart Infusion (BHI-Ox,
Oxoid LTD, Basingstoke, Hampshire, UK), BBL™ Brain
Heart Infusion (BBL-BHI, Becton Dickinson & Co.,
Sparks, MD, USA) and Bacto™ Todd Hewitt Broth (THB,
Becton Dickinson & Co., Sparks, MD, USA). Horse blood
was obtained directly by the research group and defibri-
nated, lysed, centrifuged and filtered following standard
procedures [16]. Sterile quality control agar or broth was
set simultaneously with the inoculated media in all cul-
ture processes, and incubation temperature was set to 37
and 35°C for experiments with standard and supple-
mented media, respectively. Experiments were repeated
2–3 times.
Supplementation and optimization of culture conditions 
for PRSP
The evaluation of baseline cultures variables allowed the
creation of a culture protocol that was tested with all
strains using the same phases. The results for the whole
process for each strain were standardized by hourly deter-
mination of OD600 nm and viable CFU/mL count during
Phase 2.
Statistical analysis
Data are presented as means and standard deviations. The
significance of differences in productivity of various cul-
ture media along time was determined by Repeated Meas-
ures ANOVA. For differences in maximal production
between these media, one way ANOVA was applied fol-
lowed by the Bonferroni t test. Data were stored, analyzed
and graphed with Microsoft Excel v10.2 for Windows
(Microsoft Corp., Seattle, WA, USA) and GraphPad Prism
v4.0 for Windows (GraphPad Software, San Diego, CA,
USA).
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